scholarly journals Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Viola C. Y. Chow ◽  
Thomas N. Y. Kwong ◽  
Erica W. M. So ◽  
Yolanda I. I. Ho ◽  
Sunny H. Wong ◽  
...  
2007 ◽  
Vol 56 (7) ◽  
pp. 921-929 ◽  
Author(s):  
Esvet Mutlu ◽  
Allison J. Wroe ◽  
Karla Sanchez-Hurtado ◽  
Jon S. Brazier ◽  
Ian R. Poxton

Clostridium difficile isolates (n=149) collected in south-east Scotland between August and October 2005 were typed by four different methods and their susceptibility to seven different antibiotics was determined. The aims were to define the types of strain occurring in this region and to determine whether there were any clonal relationships among them with respect to genotype and antibiotic resistance pattern. Ribotyping revealed that 001 was the most common type (n=113, 75.8 %), followed by ribotype 106 (12 isolates, 8.1 %). The majority of the isolates (96.6 %, n=144) were of toxinotype 0, with two toxinotype V isolates and single isolates of toxinotypes I, IV and XIII. PCR and restriction analysis of the fliC gene from 147 isolates gave two restriction patterns: 145 of pattern VII and two of pattern I. Binary toxin genes were detected in only three isolates: two isolates of ribotype 126, toxinotype V, and one isolate of ribotype 023, toxinotype IV. S-types showed more variation, with 64.5 % (n=40) of the common S-type (4939) and 21 % (n=13) of S-type 4741, with six other S-types (one to three isolates each). All ribotype 001 isolates were of the same S-type (4939), with three isolates of other ribotypes being this S-type. No resistance was found to metronidazole or vancomycin, with resistance to tetracycline only found in 4.3 % of the isolates. A high proportion of isolates were resistant to clindamycin (62.9 %), moxifloxacin, ceftriaxone (both 87.1 %) and erythromycin (94.8 %). Resistance to three antibiotics (erythromycin, clindamycin and ceftriaxone) was seen in 66 isolates, with erythromycin, ceftriaxone and moxifloxacin resistance seen in 96 isolates. Resistance to all four of these antibiotics was found in 62 isolates and resistance to five (the above plus tetracycline) in one isolate: a ribotype 001, toxinotype 0 strain. Whilst ribotype 001 was the most commonly encountered type, there was no evidence of clonal relationships when all other typing and antibiotic resistance patterns were taken into account.


2018 ◽  
Vol 2 (1) ◽  
pp. 37-41 ◽  
Author(s):  
Yi Han ◽  
Joan King ◽  
Marlene E Janes

Abstract Objectives: Clostridium difficile is the major cause of infectious diarrhoea in humans after antimicrobial treatment. Clostridium difficile has been isolated from food animals and meat. The main purpose of this study was to characterize C. difficile isolated from retail lettuce and determine the antibiotic resistance using five common clinical-selected antibiotics (metronidazole, vancomycin, clindamycin, erythromycin, and cefotaxime). Materials and Methods: Lettuce samples (grown in California, Arkansas, and Louisiana) were purchased from retail stores. Results: Toxigenic C. difficile was isolated from 13.8 per cent (41/297) of the lettuce samples. Among the toxigenic isolates, only 82.9 per cent (34/41) produced toxin B, 17.1 per cent (7/41) produced both toxin A and toxin B, and two of the Louisiana C. difficile isolates were identified as ribotype 027. Under the treatment of the five antibiotics, the virulence C. difficile isolates were identified as having antibiotic resistance to metronidazole, vancomycin, and erythromycin. Conclusion: The present study reports the highest prevalence of toxigenic C. difficile in US retail lettuce. The antibiotic resistance to metronidazole, vancomycin, and erythromycin of the isolated C. difficile from retail lettuces could lead to public health concerns.


2002 ◽  
Vol 59 (1) ◽  
pp. 36-40 ◽  
Author(s):  
Martin Krause

Resistenzentwicklungen machen auch bei pathogenen Bakterien gastrointestinaler Infektionen nicht Halt. So sind vor allem bei Salmonellen, Campylobacter und Helicobacter pylori in den letzten zehn Jahren eine mehrfache Erhöhung der Resistenzquoten gegen bisher erfolgreiche Antibiotika beobachtet worden. Die bedeutendsten Entwicklungen sind die Resistenzzunahme gegen Metronidazol und Clarithromycin bei Helicobacter pylori, gegen Fluorochinolone und Makrolide bei Campylobacter und gegen Fluorochinolone und Drittgeneration-Cephalosporine bei Salmonellen. Besonders besorgniserregend sind Mehrfachresistenzen, die bei allen drei Bakteriengenera vorkommen. Erfreulicherweise ist die Resistenzrate von Clostridium difficile gegen Metronidazol und Vancomycin noch sehr gering. Es bestehen keine Zweifel, dass der weit verbreitete Antibiotika-Einsatz in der Fleisch- und Geflügelindustrie die Quelle resistenter Campylobacter und Salmonellen ist. Vor allem in diesem Sektor ist eine rigorose Kontrolle und Reduktion des Antibiotika-Verbrauchs notwendig, um den aktuellen Trend zu bremsen. Folgende Regeln sind bei diesen drei «Problemkeimen» zu beachten: 1) restriktiver Antibiotika-Gebrauch, der auf etablierten Therapieindikationen beruht. Die Eradikation eines symptomlosen Helicobacter ist nicht indiziert und Antibiotika beeinflussen den Krankheitsverlauf bei den meisten Campylobacter- und Salmonella-Enterokolitiden nicht. 2) Antibiotika gezielt gegen den identifizierten Erreger, kurz und in richtiger Dosierung einsetzen. 3) Resistenzprüfungen durchführen, welche die richtige Antibiotikawahl ermöglichen und verhindern, dass wirkungslose Therapien durchgeführt werden, die lediglich die Resistenzbildung in der Bakterienflora fördern.


2017 ◽  
Vol 112 ◽  
pp. S55-S56
Author(s):  
Saloni Kapoor ◽  
Raseen Tariq ◽  
Robin Patel ◽  
Audrey Scheutz ◽  
Darrell S. Pardi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document